Revolutionary DNA Test Diagnoses a Wide Range of Infections
Researchers at UCSF have developed a metagenomic sequencing test capable of rapidly diagnosing a wide range of pathogens, including those causing neurological infections and potential pandemic threats. This test, which analyzes all nucleic acids in a sample, has been automated for respiratory samples, allowing for faster results. It has shown high accuracy in identifying infections and is expected to aid in early pandemic detection. The test has received FDA breakthrough device designation and is being commercialized by Delve Bio.
